Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 128 results for "biocon"

USFDA gives 3-month extension for breast cancer drug to Biocon
Money Control

Biocon rises 3% on zero observation from USFDA

United States Food Drug Administration (USFDA) has completed the audit of active pharmaceutical ingredients facility at Visakhapatnam, Andhra Pradesh without any observations, and so not issued form 483. Money Control, 5 hours ago
[x]  

88 images for biocon

Money Today, 1 week ago
Money Control, 1 week ago
Money Control, 1 week ago
Sify, 1 week ago
Business Standard, 1 week ago
Money Control, 3 weeks ago
Sify, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago

Biocon advances as Vishakhapatnam unit clears USFDA inspection

Biocon rose 2.37% to Rs 365.50 at 09:17 IST on BSE after the company announced that the USFDA has completed its Vishakhapatnam unit's inspection with no observations.
 Business Standard9 hours ago USFDA inspection at Bangalore facility a routine review: Biocon  Money Control1 month ago
Money Control

Biocon rallies 5% on Europe GMP approval for Malaysian insulin facility

The Europe GMP compliance certificate helps Biocon insulin, particularly insulin glargine to gain entry into the highly regulated Europe market.
 Money Control1 week ago Biocon jumps after Malaysia facility receives compliance certificate  Business Standard1 week ago Biocon's Malaysian arm gets EU certification for insulin facility  Business Standard1 week ago Biocon gets Europe GMP nod for Malaysian insulin facility  Money Control1 week ago

Biocon targets $1 bn in revenues by FY19 with new products and services

The Bengaluru-based firm has been chasing the target since 2011
 Business Standard1 week ago
Sify

Indian shares edge higher; metal stocks extend rally

* NSE index up 0.16 pct, BSE index 0.13 pct higher * Biocon hits 1-month high * Metal stocks rally for 6th straight session By Vishal Sridhar Sept 8 (Reuters) - Indian shares edged higher on Friday asmetal shares continued to rally on the back of higher ...
 Sify1 week ago BUZZ-India's Biocon hits 1-month high; receives EU compliance certificate  Sify1 week ago Indian shares fall; Reliance Industries, pharma stocks drag  Sify1 month ago Biocon slides on reports of US FDA observations  Sify1 month ago
Money Today

Biocon stock closes higher as Malaysia arm gets GMP compliance certificate

After making a positive opening, shares of the company further jumped 5.32 per cent to Rs 353 on BSE. At NSE, shares of the company gained 5.45 per cent to Rs 353. The stock closed 2.16 percent
 Money Today1 week ago Biocon up by 4% in intra-day on BSE  Sify1 week ago Biocon up 5% as Malaysia arm gets GMP compliance certificate  Business Standard1 week ago Biocon recovers after recent slide  Business Standard2 months ago
Money Control

Pharma wrap: Dr Reddy#39;s German observation, Cadila clearing US inspection more

The sector was kept busy with Dr Reddy#39;s German regulator observations, Cadila Healthcare clearing US FDA inspection with zero observations, Biocon getting EU-GMP for Malaysia insulins facility and Novartis naming Indian-origin Vas Narasimhan as its CEO.
 Money Control1 week ago

Dull End to the Week; L&T; Rallies 4%

Posted by Equitymaster Indian share markets continued to trade flat in the afternoon session amid continued caution about global risk factors such as North Korea. At the closing bell, the BSE Sensex closed higher by 25 points and the NSE Nifty finished up 5 ...
 Equitymaster.com1 week ago

Meet IBM's Transformation Man

'My simple instruction to every IBM salesperson is, "When you go to the customer, use less of this (he points to his mouth) and more of this (ear)".''Talk less, listen more",' Karan Bajwa tells Raghu Krishnan.Illustration: Dominic Xavier/Rediff.com   The top boss at IBM in the country has always had his base in Bengaluru, from where the global tech major runs its massive operations for India and the world. Not Karan Bajwa, who took charge as managing director of IBM India in January. The ...
 Rediff.com1 week ago
Money Control

Biocon tanks 9% after USFDA issues Form 483 with 10 observations to Bengaluru unit

The US Food and Drug Administration found lapses of current good manufacturing practices (cGMP) at company#39;s small molecule injectable plant in Bengaluru.
 Money Control1 month ago Biocon slips after USFDA issues 10 observations  Business Standard1 month ago Setback for Biocon's European biosimilar plans  Business Standard2 months ago Biocon tumbles on observations by French health regulator  Business Standard2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less